|
| 37788149 | Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children. | Cancer | 2024 |
| 37800450 | Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel. | Genet Med | 2024 |
| 38007624 | Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child? | Genet Med | 2024 |
| 36595372 | Views of Adolescents and Young Adults with Cancer and Their Oncologists Toward Patients' Participation in Genomic Research. | J Adolesc Young Adult Oncol | 2023 |
| 37289514 | Identification of USP9X as a leukemia susceptibility gene. | Blood Adv | 2023 |
| 37115922 | The genomic landscape of familial glioma. | Sci Adv | 2023 |
| 37366624 | Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site. | Cancer | 2023 |
| 37366551 | Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study. | Pediatr Hematol Oncol | 2023 |
| 37194615 | TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report. | Pediatr Blood Cancer | 2023 |
| 36813544 | Germline pathogenic <i>SMARCA4</i> variants in neuroblastoma. | J Med Genet | 2023 |
| 36600593 | Optimising clinical care through <i>CDH1</i>-specific germline variant curation: improvement of clinical assertions and updated curation guidelines. | J Med Genet | 2023 |
| 34793247 | Importance of Population-Based Cancer Risk Information in the Care of Patients With Rare Genetic Disorders. | J Clin Oncol | 2022 |
| 35487348 | A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels. | J Mol Diagn | 2022 |
| 35622075 | FOCAD Indel in a Family With Juvenile Polyposis Syndrome. | J Pediatr Gastroenterol Nutr | 2022 |
| 35713195 | Clinical and molecular features of pediatric cancer patients with Lynch syndrome. | Pediatr Blood Cancer | 2022 |
| 36001348 | Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition. | Cancer Prev Res (Phila) | 2022 |
| 36063163 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35101336 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35245469 | The annual ASHG dinner. | Am J Hum Genet | 2022 |
| 35306447 | Evolution of germline TP53 variant classification in children with cancer. | Cancer Genet | 2022 |
| 35026696 | Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome. | Cancer Genet | 2022 |
| 32313107 | Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome. | Leukemia | 2021 |
| 34651095 | Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an <i>NTRK2</i> Fusion: The Impact of Integrated Genomic Profiling. | JCO Precis Oncol | 2021 |
| 34065162 | Pediatric Rhabdomyosarcoma: Epidemiology and Genetic Susceptibility. | J Clin Med | 2021 |
| 34207141 | Pediatric Oncologists' Experiences Returning and Incorporating Genomic Sequencing Results into Cancer Care. | J Pers Med | 2021 |
| 34086347 | Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood. | J Pathol | 2021 |
| 33372952 | Germline Cancer Predisposition Variants inâ¿¿Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. | J Natl Cancer Inst | 2021 |
| 33300245 | Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants. | Hum Mutat | 2021 |
| 33097490 | Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing <i>SMAD4</i>/<i>BMPR1A</i> Variant. | Cancer Prev Res (Phila) | 2021 |
| 32469081 | Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases. | Cancer | 2020 |
| 31915397 | A brief history of human disease genetics. | Nature | 2020 |
| 33134832 | Male Sex and the Risk of Childhood Cancer: The Mediating Effect of Birth Defects. | JNCI Cancer Spectr | 2020 |
| 30581014 | Agents of empathy: How medical interpreters bridge sociocultural gaps in genomic sequencing disclosures with Spanish-speaking families. | Patient Educ Couns | 2019 |
| 31645350 | A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen). | Cold Spring Harb Mol Case Stud | 2019 |
| 31648317 | ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants. | Blood Adv | 2019 |
| 30181607 | Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): lessons learned and plans for the future. | Genet Med | 2019 |
| 29895853 | Genome-wide sequencing in acutely ill infants: genomic medicine's critical application? | Genet Med | 2019 |
| 31303264 | Mutations in ANAPC1, Encoding a Scaffold Subunit of the Anaphase-Promoting Complex, Cause Rothmund-Thomson Syndrome Type 1. | Am J Hum Genet | 2019 |
| 31186522 | Responsibility, culpability, and parental views on genomic testing for seriously ill children. | Genet Med | 2019 |
| 31219523 | Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. | JAMA Oncol | 2019 |
| 30977242 | Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. | Pediatr Blood Cancer | 2019 |
| 31082280 | Genetic Predisposition to Childhood Cancer in the Genomic Era. | Annu Rev Genomics Hum Genet | 2019 |
| 31050187 | Severe therapy-related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres. | Pediatr Blood Cancer | 2019 |
| 30523343 | Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework. | Genet Med | 2019 |
| 30398677 | Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed. | Prenat Diagn | 2019 |
| 30482469 | Exome sequencing disclosures in pediatric cancer care: Patterns of communication among oncologists, genetic counselors, and parents. | Patient Educ Couns | 2019 |
| 30287922 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 30670880 | Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 30504931 | Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels. | Genet Med | 2019 |
| 30302893 | Framework for microRNA variant annotation and prioritization using human population and disease datasets. | Hum Mutat | 2019 |